Showing 51-60 of 169 results for "".
Why Are Dermatologists Not Writing Biologics?
https://practicaldermatology.com/topics/practice-management/why-are-dermatologists-inoti-writing-biologics/23427/Biologics have been shown to be both safe and effective for a variety of indications, so why don’t more dermatologists prescribe them?Learn More About REVIAN® Red Hair Growth System
https://practicaldermatology.com/topics/hair-nails/learn-more-about-revian-red-hair-growth-system/19750/Discover a new option for hair loss patients! REVIAN Red is a patented dual-band LED wireless cap for at-home use ten minutes daily. Click Here to Become a REVIAN Red Professional. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton clDr. Garden Discusses Experience with the VariLite Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-garden-discusses-experience-with-gemini-laser/19467/"The VariLite system is a wonderful choice for those people who want to enter into the laser arena. Because many, many patients have vessels which naturally occur as they grow older or especially those who develop rosacea later in life, this is something that many practices have the need for treatExploring the Benefits of Nitric Oxide for Hair Loss Patients Through REVIAN® Red
https://practicaldermatology.com/topics/hair-nails/exploring-the-benefits-of-nitric-oxide-for-hair-loss-patients-through-revian-red/19753/Learn more about the mechanism of action of the new REVIAN Red Dual-Band LED light therapy cap and what makes it unique from other at-home FDA-cleared devices. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton classifications of IIaUsing the REVIAN Red System for Your Hair Loss Patients
https://practicaldermatology.com/topics/hair-nails/using-the-revian-red-system-for-your-hair-loss-patients/19754/Hear a few practical insights from hair loss experts Suneel Chilukuri, MD, Joel Cohen, MD and Michael Gold, MD about how they incorporate the new REVIAN Red dual-band LED wireless cap and smart app in their practices! REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growthGolden Achievement: Dr. Michael Gold on Lifetime Award at CSF 2016
https://practicaldermatology.com/topics/practice-management/golden-achievement-dr-michael-gold-on-lifetime-award-at-csf-2016/18712/Michael H. Gold, MD was recognized December 2016 at the Cosmetic Surgery Forum in Las Vegas with the Lifetime Contribution to Aesthetics Award by CSF Founder Joel Schlessinger, MD. Speaking about the award, Dr. Gold shares his perspective as a global educator and practitioner (Dr. Gold cofounded theHispanic Home Remedies (remedios caseros) in the Management of Dermatologic Disease: A Focused Review
https://practicaldermatology.com/columns/clinical-focus-1/hispanic-home-remedies-iremedios-caserosi-in-the-management-of-dermatologic-disease-a-focused-review/23718/Chamomile, aloe vera, green tea, honey, and apple cider vinegar are popular remedios caseros.Protecting Assets in a Divorce
https://practicaldermatology.com/topics/practice-management/protecting-assets-in-a-divorce/18771/Statistics show that half of marriages end in divorce. Financial consequences can be significant. OJM Group principal David Mandell, JD, MBA, discusses how physicians can protect their assets in the pre-marital and the marital stages in the event of a divorce. Always contact local counsel before taAsset Protection 101: What Every Dermatologist Should Know
https://practicaldermatology.com/topics/practice-management/asset-protection-101-what-every-dermatologist-should-know/18875/OJM Group principal David Mandell, JD, MBA, reviews the importance of protecting assets for physicians, introduces the asset protection "sliding scale" and outlines basic tools for protecting personal and practice assets.To obtain a free copy of "Wealth Protection Planning for Dermatologists" visit- Study: Test Improves the Risk Stratification of Patients with Stage I Melanomahttps://practicaldermatology.com/news/study-finds-decisiondx-melanoma-significantly-improves-the-risk-stratification-of-patients-with-stage-i-melanoma-compared-to-american-joint-committee-on-cancer-8th-edition-staging/2462252/Results from a recent study showed the potential of a 31-gene expression profile (31-GEP) test in improving the prognosis for patients diagnosed with stage I cutaneous melanoma. Despite being considered at low risk for metastasis or melanoma-specific death, patients with stage I cutaneous